Related Experiment Video

Updated: Apr 4, 2026

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

17.9K

Antifungal T cells--progress in manufacture and prospects for the clinic

David Gottlieb1

  • 1Department of Haematology, University of Sydney, Program Director BMT, Head Cell Therapies, Westmead Hospital Sydney, Sydney, Australia.

Cytotherapy
|September 9, 2015
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Engineering Chimeric Antigen Receptor-Natural Killer Cells Targeting Fungal Infections Using the Non-viral Sleeping Beauty Transposon System
08:29

Engineering Chimeric Antigen Receptor-Natural Killer Cells Targeting Fungal Infections Using the Non-viral Sleeping Beauty Transposon System

Published on: October 4, 2024

1.4K
Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
06:03

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Published on: September 20, 2024

1.9K

Related Experiment Videos

Last Updated: Apr 4, 2026

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

17.9K
Engineering Chimeric Antigen Receptor-Natural Killer Cells Targeting Fungal Infections Using the Non-viral Sleeping Beauty Transposon System
08:29

Engineering Chimeric Antigen Receptor-Natural Killer Cells Targeting Fungal Infections Using the Non-viral Sleeping Beauty Transposon System

Published on: October 4, 2024

1.4K
Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
06:03

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Published on: September 20, 2024

1.9K

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

62
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to...
62

Articles linked to this work by shared authors, journal, and citation graph.

Boosting the Predictive Power of Virus-Specific T-Cell Clinical Trials via Generative Models.

Computational and structural biotechnology journal·2026

Why biological naturalism? Because consciousness requires having your own good.

The Behavioral and brain sciences·2026

ANZTCT cytomegalovirus practice survey for allogeneic haemopoietic stem cell transplant and cellular therapy recipients in Australia and New Zealand.

Internal medicine journal·2026

Allogeneic stem cell transplantation for mantle cell lymphoma can achieve durable remission and myeloablative conditioning is associated with inferior survival: an Australian and New Zealand Transplant & Cellular Therapies registry study.

Internal medicine journal·2026

Prime editing enables drug-controllable T-cell therapies with clinical immunosuppression.

Blood·2026

Third-Party Viral Specific T Cells for Immunocompromised Hosts and Access Barriers: A Review and Commentary by an Expert Panel from ASTCT.

Transplantation and cellular therapy·2026

WJ-MSCs modulate Treg phenotypic and transcriptional profiles in T1DM: comparative insights into direct and indirect mechanisms.

Cytotherapy·2026

Multicenter validation study on post-thaw viability testing of cryopreserved hematopoietic progenitor cell products.

Cytotherapy·2026

Overcoming access barriers in European CAR-T therapy: the role of decentralized manufacturing and the EASYGEN framework.

Cytotherapy·2026

From classroom to cleanroom: building a skilled cell and gene therapy workforce.

Cytotherapy·2026

The evolving role of umbilical cord blood in transplantation, immunotherapy, and regenerative medicine: a brief contemporary review by the ISCT lab practices committee.

Cytotherapy·2026

MSC-delivered high-affinity variants of soluble PD1 lead to tumor regression.

Cytotherapy·2026

A murine model of amyloid enhanced tauopathy: progressive changes in tau pathology and behavior.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

Integrating deep learning model for precision design of MERS antibodies with augmented affinity against SARS-CoV-2.

Journal of biomolecular structure & dynamics·2026

Impact of the physico-chemical properties of surface-initiated polymer brushes on siRNA binding and transfection efficiency.

Biomaterials science·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us